[Supplementary]Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF

Post time 2024-4-20 16:15:49

journal：Journal of the American College of Cardiology

Authors：Toru Kondo; Ulrik M. Mogensen; Atefeh Talebi; Samvel B. Gasparyan; Ross T. Campbell; Kieran F. Docherty; Rudolf A. de Boer; Silvio E. Inzucchi; Lars Kober; Mikhail N. Kosiborod; Felipe A. Martinez; Marc S. Sabatine; Olof Bengtsson; Mikaela Sjostrand; Muthiah Vaduganathan; Scott D. Solomon; Pardeep S. Jhund; John JV. McMurray

Published date：2024-3-

DOI：10.1016/j.jacc.2024.03.385

PDF link：https://www.sciencedirect.com/sc ... 735109724066713/pdf

Article link：http://dx.doi.org/10.1016/j.jacc.2024.03.385

Article Source：Elsevier BV。

Remark：

Post time 2024-4-20 16:15:50

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2024-4-20 16:16:29

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2024-4-20 16:23:24

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2024-4-20 16:24:02

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] [Supplementary]Dapagliflozin and days of full health lost through death, hospitalization, and impaired well-being in DAPA-HF

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today